Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Rogler

Showing results (461-470 of 547) with videos related to

Pageof 55
Sort By:
Journal of Crohn'S & Colitis|June 30, 2026
Multiomics analysis dissects the molecular foundation of perianal fistulas associated with Crohn's disease and of cryptoglandular originCéline Mamie, Daniela Cabalzar-Wondberg, Matthias Turina, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 31, 2016
The perspective of celiac disease patients on emerging treatment options and non-celiac gluten sensitivityThomas Greuter, Sandra Schmidlin, Jaqueline Lattmann, et al.
Gastroenterology|March 31, 2018
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's DiseaseSilvio Danese, Stefanos Bonovas, Anthony Lopez, et al.
Journal of Clinical Gastroenterology|September 17, 2016
Celiac Disease is Misdiagnosed Based on Serology Only in a Substantial Proportion of PatientsStephan R Vavricka, Teresa Stelzer, Jaqueline Lattmann, et al.
Alimentary Pharmacology & Therapeutics|August 1, 2024
Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension studyBrian G Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, et al.
Journal for Immunotherapy of Cancer|February 8, 2022
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancerPhilipp Busenhart, Ana Montalban-Arques, Egle Katkeviciute, et al.
Mucosal Immunology|October 4, 2018
Succinate receptor mediates intestinal inflammation and fibrosisDulce C Macias-Ceja, Dolores Ortiz-Masiá, Pedro Salvador, et al.
Nature Communications|July 26, 2017
Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activationJesus Cosin-Roger, Simona Simmen, Hassan Melhem, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 28, 2014
Downregulation of duodenal SLC transporters and activation of proinflammatory signaling constitute the early response to high altitude in humansKacper A Wojtal, Alexandra Cee, Silvia Lang, et al.
Plos One|September 16, 2022
Effect of closed and permanent stoma on disease course, psychological well-being and working capacity in Swiss IBD cohort study patientsRahel Bianchi, Barry Mamadou-Pathé, Roland von Känel, et al.
Pageof 55

Showing results (461-470 of 547) with videos related to

Sort By:
Pageof 55
Journal of Crohn'S & Colitis|June 30, 2026
Multiomics analysis dissects the molecular foundation of perianal fistulas associated with Crohn's disease and of cryptoglandular originCéline Mamie, Daniela Cabalzar-Wondberg, Matthias Turina, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 31, 2016
The perspective of celiac disease patients on emerging treatment options and non-celiac gluten sensitivityThomas Greuter, Sandra Schmidlin, Jaqueline Lattmann, et al.
Gastroenterology|March 31, 2018
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's DiseaseSilvio Danese, Stefanos Bonovas, Anthony Lopez, et al.
Journal of Clinical Gastroenterology|September 17, 2016
Celiac Disease is Misdiagnosed Based on Serology Only in a Substantial Proportion of PatientsStephan R Vavricka, Teresa Stelzer, Jaqueline Lattmann, et al.
Alimentary Pharmacology & Therapeutics|August 1, 2024
Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension studyBrian G Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, et al.
Journal for Immunotherapy of Cancer|February 8, 2022
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancerPhilipp Busenhart, Ana Montalban-Arques, Egle Katkeviciute, et al.
Mucosal Immunology|October 4, 2018
Succinate receptor mediates intestinal inflammation and fibrosisDulce C Macias-Ceja, Dolores Ortiz-Masiá, Pedro Salvador, et al.
Nature Communications|July 26, 2017
Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activationJesus Cosin-Roger, Simona Simmen, Hassan Melhem, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 28, 2014
Downregulation of duodenal SLC transporters and activation of proinflammatory signaling constitute the early response to high altitude in humansKacper A Wojtal, Alexandra Cee, Silvia Lang, et al.
Plos One|September 16, 2022
Effect of closed and permanent stoma on disease course, psychological well-being and working capacity in Swiss IBD cohort study patientsRahel Bianchi, Barry Mamadou-Pathé, Roland von Känel, et al.
Pageof 55